Nuveen Asset Management LLC Cuts Stock Position in Integer Holdings Co. (NYSE:ITGR)

Nuveen Asset Management LLC decreased its holdings in Integer Holdings Co. (NYSE:ITGR - Free Report) by 19.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 198,246 shares of the medical equipment provider's stock after selling 46,590 shares during the period. Nuveen Asset Management LLC owned 0.59% of Integer worth $26,272,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Mather Group LLC. increased its holdings in Integer by 304.3% during the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 143 shares during the period. Lee Danner & Bass Inc. acquired a new stake in Integer in the fourth quarter valued at approximately $27,000. R Squared Ltd purchased a new position in Integer during the 4th quarter worth $44,000. Sterling Capital Management LLC grew its stake in shares of Integer by 472.9% during the fourth quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock worth $45,000 after acquiring an additional 279 shares during the last quarter. Finally, Principal Securities Inc. raised its holdings in shares of Integer by 31.2% in the fourth quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider's stock worth $85,000 after buying an additional 152 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.

Analyst Ratings Changes

Several analysts have commented on the stock. Raymond James lifted their price objective on shares of Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, April 25th. Benchmark reduced their target price on Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research note on Friday, April 25th. Oppenheimer lowered Integer from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. KeyCorp lowered their price target on shares of Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Finally, Wall Street Zen raised Integer from a "sell" rating to a "hold" rating in a research note on Monday, May 19th. Two equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $145.00.

Integer Stock Down 1.5%

NYSE ITGR traded down $1.77 during trading hours on Wednesday, hitting $119.87. 30,862 shares of the company were exchanged, compared to its average volume of 514,256. Integer Holdings Co. has a 52-week low of $104.93 and a 52-week high of $146.36. The firm has a market cap of $4.18 billion, a price-to-earnings ratio of 35.67, a PEG ratio of 1.72 and a beta of 1.03. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. The company has a 50 day moving average of $118.47 and a two-hundred day moving average of $128.95.

Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. Integer had a net margin of 6.92% and a return on equity of 11.65%. The firm had revenue of $437.39 million during the quarter, compared to the consensus estimate of $428.51 million. During the same quarter in the previous year, the firm posted $1.14 earnings per share. The company's revenue was up 7.3% compared to the same quarter last year. Equities research analysts anticipate that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Insider Activity at Integer

In other news, CEO Joseph W. Dziedzic sold 338,975 shares of the firm's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the transaction, the chief executive officer now directly owns 47,000 shares in the company, valued at approximately $5,788,990. This trade represents a 87.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 2.16% of the company's stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.